Esophagitis in combined modality therapy for locally advanced non-small cell lung cancer. [electronic resource]
Producer: 19990713Description: 90-6 p. digitalISSN:- 1053-4296
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents, Phytogenic -- adverse effects
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Combined Modality Therapy
- Esophagitis -- etiology
- Female
- Humans
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Multivariate Analysis
- Paclitaxel -- adverse effects
- Prospective Studies
- Radiotherapy -- adverse effects
- Survival Analysis
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.